Samir, O.; Kobayashi, N.; Nishino, T.; Siyam, M.; Yadav, M.K.; Inoue, Y.; Takahashi, S.; Hamada, M.
Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma. Int. J. Mol. Sci. 2022, 23, 9945.
https://doi.org/10.3390/ijms23179945
AMA Style
Samir O, Kobayashi N, Nishino T, Siyam M, Yadav MK, Inoue Y, Takahashi S, Hamada M.
Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma. International Journal of Molecular Sciences. 2022; 23(17):9945.
https://doi.org/10.3390/ijms23179945
Chicago/Turabian Style
Samir, Omar, Naohiro Kobayashi, Teppei Nishino, Mennatullah Siyam, Manoj Kumar Yadav, Yuri Inoue, Satoru Takahashi, and Michito Hamada.
2022. "Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma" International Journal of Molecular Sciences 23, no. 17: 9945.
https://doi.org/10.3390/ijms23179945
APA Style
Samir, O., Kobayashi, N., Nishino, T., Siyam, M., Yadav, M. K., Inoue, Y., Takahashi, S., & Hamada, M.
(2022). Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma. International Journal of Molecular Sciences, 23(17), 9945.
https://doi.org/10.3390/ijms23179945